…The panel voted after hearing presentations on a serious combination of blood clotting and low blood platelet levels that has been seen at higher than background rates in people who have gotten the J&J vaccine. The link prompted a near-nationwide pause in administration of the vaccine in April but health agencies lifted the pause after determining the benefits of the shot outweighed its risks. Since then, though, the number of confirmed cases of post-vaccination thrombosis with thrombocytopenia syndrome (TTS) has climbed, particularly in middle-aged women, CDC experts told members.
